Showing results (371-380 of 490) with videos related to
Sort By:
Pageof 49
Physical Review Letters|January 11, 2020
Ultrasmall Moment Incommensurate Spin Density Wave Order Masking a Ferromagnetic Quantum Critical Point in NbFe_{2}P G Niklowitz, M Hirschberger, M Lucas, et al.Neurology|August 23, 2006
A new type of leukoencephalopathy with metaphyseal chondrodysplasia maps to Xq25-q27B A Neubauer, I Stefanova, C A Hübner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapySamir E Witta, Robert M Jotte, Katrik Konduri, et al.Scientific Reports|November 30, 2016
Stepwise onset of the Icehouse world and its impact on Oligo-Miocene Central Asian mammalsMathias Harzhauser, Gudrun Daxner-Höck, Paloma López-Guerrero, et al.Clinical Colorectal Cancer|August 23, 2011
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancerAllen L Cohn, Grace C Shumaker, Pankaj Khandelwal, et al.Allergy|December 22, 2015
Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standardM Himly, A Nandy, H Kahlert, et al.Investigational New Drugs|May 10, 2006
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group studyRobert P Whitehead, Sheryl McCoy, John S Macdonald, et al.Peerj|June 27, 2022
Adapting mark-recapture methods to estimating accepted species-level diversity: a case study with terrestrial GastropodaGary Rosenberg, Kurt Auffenberg, Ruud Bank, et al.Cancers|December 10, 2021
Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate CancerRobert Wiebringhaus, Matteo Pecoraro, Heidi A Neubauer, et al.Journal of Oncology Practice|June 12, 2010
Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community settingMarcus A Neubauer, J Russell Hoverman, Michael Kolodziej, et al.Pageof 49